African-American Crack Abusers and Drug Treatment Initiation: Barriers and Effects of a Pretreatment Intervention
Overview
Affiliations
Background: Individual and sociocultural factors may pose significant barriers for drug abusers seeking treatment, particularly for African-American crack cocaine abusers. However, there is evidence that pretreatment interventions may reduce treatment initiation barriers. This study examined the effects of a pretreatment intervention designed to enhance treatment motivation, decrease crack use, and prepare crack abusers for treatment entry.
Methods: Using street outreach, 443 African-American crack users were recruited in North Carolina and randomly assigned to either the pretreatment intervention or control group.
Results: At 3-month follow-up, both groups significantly reduced their crack use but the intervention group participants were more likely to have initiated treatment.
Conclusion: The intervention helped motivate change but structural barriers to treatment remained keeping actual admissions low. Policy makers may be interested in these pretreatment sites as an alternative to treatment for short term outcomes.
Duopah Y, Moran L, Elmusharaf K, Kelly D BMC Health Serv Res. 2024; 24(1):1450.
PMID: 39578888 PMC: 11583639. DOI: 10.1186/s12913-024-11920-1.
Associations between traumatic life events and substance use among Black Men who are incarcerated.
Jester J, Miller-Roenigk B, Wheeler P, Stevens-Watkins D J Ethn Subst Abuse. 2024; :1-19.
PMID: 38511975 PMC: 11415548. DOI: 10.1080/15332640.2024.2326948.
Psychosocial interventions for stimulant use disorder.
Minozzi S, Saulle R, Amato L, Traccis F, Agabio R Cochrane Database Syst Rev. 2024; 2:CD011866.
PMID: 38357958 PMC: 10867898. DOI: 10.1002/14651858.CD011866.pub3.
Tardelli V, Berro L, Gerra G, Tadonio L, Bisaga A, Fidalgo T Addict Biol. 2023; 28(4):e13271.
PMID: 37016755 PMC: 10499006. DOI: 10.1111/adb.13271.
Perceived need for drug treatment among African American male drug-using prisoners.
Dogan J, Stevens-Watkins D, Knighton J, Wheeler P, Hargons C J Subst Abuse Treat. 2020; 120:108166.
PMID: 33298302 PMC: 7733029. DOI: 10.1016/j.jsat.2020.108166.